Wicklein, D., Leal, N. R., Salamon, J., Thamer, M., Herrmann, H., Valent, P., . . . Ullrich, S. (2012). Nilotinib and imatinib are comparably effective in reducing growth of human eosinophil leukemia cells in a newly established xenograft model. Public Library of Science (PLoS).
Cita Chicago Style (17a ed.)Wicklein, Daniel, Nuno Ramos Leal, Johannes Salamon, Mohammed Thamer, Harald Herrmann, Peter Valent, Udo Schumacher, y Sebastian Ullrich. Nilotinib and Imatinib Are Comparably Effective in Reducing Growth of Human Eosinophil Leukemia Cells in a Newly Established Xenograft Model. Public Library of Science (PLoS), 2012.
Cita MLA (8a ed.)Wicklein, Daniel, et al. Nilotinib and Imatinib Are Comparably Effective in Reducing Growth of Human Eosinophil Leukemia Cells in a Newly Established Xenograft Model. Public Library of Science (PLoS), 2012.